Immunogenicity and Safety of Beta Variant COVID-19 Vaccine AZD2816 and AZD1222 (chadox1 Ncov-19) As Primary-Series Vaccination for Previously Unvaccinated Adults in Brazil, South Africa, Poland, and the UK: a Randomised, Partly Double-Blinded, Phase 2/3 Non-Inferiority Immunobridging Study
LANCET MICROBE（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined